Astellas publish series of Beta 3 adrenoceptor agonsits « GPCR News

Tags

5-HT1A 5-HT2 5-HT2A 5-HT3 5-HT4 5-ht6 5HT1A 5HT1D 5HT2 5HT2A 5HT3 5HT4 5ht6 agonist Angiotensin II AT1 antagonist Astrazeneca Beta 2 adrenoceptor Cannabinoid CB1 Daiichi-Sankyo Dopamine Dopamine D2 Fentanyl ghrelin GlaxoSmithkline GLP-1 gpcr GSK Histamine H1 Licensing Lilly Merck Muscarinic Opioid Opioid mu phase I phase II phase III Preclinical regulatory Research Sanofi-Aventis TRPV1 Vanilloid
July 2008

M T W T F S S

« Jun Aug »

1 2 3 4 5 6

7 8 9 10 11 12 13

14 15 16 17 18 19 20

21 22 23 24 25 26 27

28 29 30 31

Astellas publish series of Beta 3 adrenoceptor agonsits

Posted on July 25, 2008 by crimsoncanary

Astellas have published a series of adrenoceptor Beta 3 agonists

Filed under: Uncategorized | Tagged: Adrenoceptor, Astellas, beta 3, Beta 3 adrenoceptor, Preclinical, Research

« EU gives positive opinion on EpiCepts Ceplene in AML NexMed receive non approvable letter for topical alprostadil »

Leave a Reply